Medication-Induced Blood Dyscrasias: Diagnosis, Treatment And Prevention
Author: Jassin M. Jouria, MD
(Click author's name for bio)
Pharmacology: 0.5 hour
Jassin M. Jouria, MD
Jassin M. Jouria is a medical doctor, professor of academic medicine, and medical author. He graduated from Ross University School of Medicine and has completed his clinical clerkship training in various teaching hospitals throughout New York, including King’s County Hospital Center and Brookdale Medical Center, among others. Dr. Jouria has served as a test prep tutor and instructor for Kaplan. He has developed several medical courses and curricula for a variety of educational institutions. Dr. Jouria has also served on multiple levels in the academic field including faculty member and Department Chair. Dr. Jouria continues to serves as a Subject Matter Expert for several continuing education organizations covering multiple basic medical sciences.
Rated 4.7 out of 5.0 based on 949 reviews
South Carolina Information
Pharmacotherapeutics Credits: 0.5
Related to prescribing controlled substances: 0
Although drug-induced hematologic disorders are less common than other types of adverse reactions, they are associated with significant morbidity and mortality. Some agents, such as hemolytics, cause predictable hematologic disease, but others induce idiosyncratic reactions not directly related to the drug’s pharmacology. The most important part of managing hematologic disorders is the prompt recognition that a problem exists. The main mechanisms to manage hematologic disorders include vigilance to observe signs and symptoms indicating a blood disorder and patient education of the warning symptoms to alert them of the need to report a condition to their primary care provider or an emergency health team. Part 2 of this course deals with Diagnosis, Treatment And Prevention.
- Diagnosis Of Blood Dyscrasias
- The Complete Blood Count (CBC)
- Bone Marrow Disease And Examination
- Treatment And Management
- Reporting A Drug-Induced Blood Dyscrasia